← Leaderboards
Ramkumar Menon
University Of Texas Med Br Galveston
$9,581,117
Attributed
$16,015,945
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.6M · FY2011–25$10M$7.5M$5M$2.5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,042,592 · 17
By mechanism
U2C$5,068,956 · 3
R01$4,667,339 · 3
R24$2,767,708 · 1
UH3$2,731,098 · 2
UG3$1,491,871 · 1
UH2$842,227 · 1
Top collaborators
- Arum Han18 shared
- Ananth Kumar Kammala4 shared
- Maged Costantine3 shared
- Kristina M Adams Waldorf2 shared
- Elizabeth A Bonney2 shared
- Ivan Rusyn2 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Ananth Kumar Kammala$1,453,131
Others in their field
Top investigators on “Pregnancy”
- Chanza Baytop · Westat, Inc.$271,217,917
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$158,777,707
- Barbara Driver · Westat, Inc.$117,058,181
- Myron S Cohen · Family Health International$101,800,876
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
Research focus
PregnancyCellsPremature BirthFetal MembranesFetusTissuesResponseInflammationBirthInflammatoryFetalIn VitroPhysiologicalInfectionMembraneUterusPathway InteractionsPathologicPlacentaMediatingReportingAmnionPharmaceutical PreparationsMothers
Grant awards (45)
A Translational Center for Microphysiological Systems-Based Drug Development Tools for Pregnancy and Women's Health$1,496,973
U2C · FY2025 · TR · contact PI
Developing Extracellular Vesicle Based MPRINT Translational Resource Platform for Monitoring Therapeutics Response During Pregnancy$1,010,469
R24 · FY2025 · HD
Resources Core$748,425
U2C · FY2025 · TR · contact PI
IL-10 Delivery Using Extracellular Vesicles to Delay Preterm Birth$743,340
R01 · FY2025 · HD · contact PI
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip$743,099
UH3 · FY2025 · TR
Administrative Core$262,687
U2C · FY2025 · TR · contact PI
3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth$233,262
UH3 · FY2025 · TR · contact PI
A Translational Center for Microphysiological Systems-Based Drug Development Tools for Pregnancy and Women's Health$1,529,674
U2C · FY2024 · TR · contact PI
Developing Extracellular Vesicle Based MPRINT Translational Resource Platform for Monitoring Therapeutics Response During Pregnancy$924,057
R24 · FY2024 · HD
Resources Core$756,268
U2C · FY2024 · TR · contact PI
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip$749,159
UH3 · FY2024 · TR
IL-10 Delivery Using Extracellular Vesicles to Delay Preterm Birth$635,254
R01 · FY2024 · HD · contact PI
Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis$435,534
R01 · FY2024 · HD · contact PI
Administrative Core$274,929
U2C · FY2024 · TR · contact PI
3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth$234,053
UH3 · FY2024 · TR · contact PI
Developing IL-10 encapsulated exosomes as novel therapeutics for spontaneous preterm birth$80,000
R03 · FY2024 · HD
Developing Extracellular Vesicle Based MPRINT Translational Resource Platform for Monitoring Therapeutics Response During Pregnancy$833,182
R24 · FY2023 · HD
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip$771,525
UH3 · FY2023 · TR
Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis$439,932
R01 · FY2023 · HD · contact PI
3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth$412,626
UH2 · FY2023 · TR · contact PI
Developing IL-10 encapsulated exosomes as novel therapeutics for spontaneous preterm birth$80,000
R03 · FY2023 · HD
Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis$439,932
R01 · FY2022 · HD · contact PI
3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth$429,601
UH2 · FY2022 · TR · contact PI
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip$722,985
UG3 · FY2021 · TR
Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis$444,593
R01 · FY2021 · HD · contact PI
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip$77,866
UG3 · FY2021 · TR
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip$691,020
UG3 · FY2020 · TR
Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis$552,500
R01 · FY2020 · HD · contact PI
Administrative Supplement to Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis$280,934
R01 · FY2020 · HD · contact PI
Engineering Fetal Cell Exosomes to contain HMGB1: Its trafficking and role as an inflammatory activator in uterine cells$145,500
R21 · FY2020 · AI · contact PI
Fetal Cell Senescence Signals Initiation of Parturition$133,176
R01 · FY2020 · HD · contact PI
Static state of epithelial mesenchymal transition in fetal membrane cells: a novel inflammatory pathway to parturition$79,000
R03 · FY2020 · HD · contact PI
Engineering Fetal Cell Exosomes to contain HMGB1: Its trafficking and role as an inflammatory activator in uterine cells$241,000
R21 · FY2019 · AI · contact PI
Fetal Membranes: An In-Vivo Model for Developmental Senescence and its Consequences$195,773
R21 · FY2019 · AG
Fetal Cell Senescence Signals Initiation of Parturition$135,380
R01 · FY2019 · HD · contact PI
Static state of epithelial mesenchymal transition in fetal membrane cells: a novel inflammatory pathway to parturition$79,000
R03 · FY2019 · HD · contact PI
Fetal Membranes: An In-Vivo Model for Developmental Senescence and its Consequences$249,429
R21 · FY2018 · AG
Fetal Cell Senescence Signals Initiation of Parturition$139,818
R01 · FY2018 · HD · contact PI
Fetal Cell Senescence Signals Initiation of Parturition$142,213
R01 · FY2017 · HD · contact PI
ROS-Induced p38 MAPK activation: A Novel Pathway to Preterm Birth$77,500
R03 · FY2017 · HD · contact PI
Fetal Cell Senescence Signals Initiation of Parturition$144,733
R01 · FY2016 · HD · contact PI
ROS-Induced p38 MAPK activation: A Novel Pathway to Preterm Birth$77,500
R03 · FY2016 · HD · contact PI
Diversity & racial disparity in fetal membrane cytokine signature during infectio$81,800
R03 · FY2012 · HD · contact PI
Diversity & racial disparity in fetal membrane cytokine signature during infectio$78,832
R03 · FY2011 · HD · contact PI
Diversity & racial disparity in fetal membrane cytokine signature during infectio$8,059
R03 · FY2011 · HD · contact PI